Congress trades in Arrowhead Pharmaceuticals (ARWR)
Healthcare · Biotechnology
1 member of Congress has disclosed 1 trade in Arrowhead Pharmaceuticals (ARWR) since 2023: 0 buys and 1 sale. The most recent was disclosed on Feb 24, 2023.
- Trades disclosed
- 1
- Members trading
- 1
- Buys / sells
- 0 / 1
- Reported value
- $1K–$15K
Who traded ARWR
MemberBuysSalesLast disclosed
- Rep. Daniel S. Goldman (D-NY-10)0 buys · 1 sale01Feb 24, 2023
All trades
DisclosedTradeAmount
- Feb 24, 2023$1K–$15K
Rep. Daniel S. Goldman (D-NY-10)
Sold Arrowhead Pharmaceuticals ARWR
$1K–$15K · Traded Jan 31, 2023 · disclosed Feb 24, 2023
From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.